Literature DB >> 17920189

Amyotrophic lateral sclerosis patients and ocular ptosis.

Susana Pinto1, Mamede de Carvalho.   

Abstract

Ptosis is not a feature observed in amyotrophic lateral sclerosis (ALS). We describe two old women with bulbar-onset ALS and rapid progression, in whom ptosis and diplopia were noted. They did not improve on pyridostigmine or steroids. Antibodies against acetylcholine receptor were negative, thymoma was excluded, but neurophysiological showed marked neuromuscular transmission failure in orbicularis oculi. We discuss the association between ALS and ocular myasthenia gravis in these cases.

Entities:  

Mesh:

Year:  2007        PMID: 17920189     DOI: 10.1016/j.clineuro.2007.08.022

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

1.  Ptosis and bulbar onset: an unusual phenotype of familial ALS?

Authors:  Fabiola De Marchi; L Corrado; E Bersano; M F Sarnelli; V Solara; S D'Alfonso; R Cantello; L Mazzini
Journal:  Neurol Sci       Date:  2017-11-13       Impact factor: 3.307

2.  Repetitive nerve stimulation test in amyotrophic lateral sclerosis with predominant oropharyngeal manifestations.

Authors:  Jee Young Kim; Kee Duk Park; Seung-Min Kim; Il Nam Sunwoo
Journal:  J Clin Neurol       Date:  2011-03-31       Impact factor: 3.077

3.  A Gaze Independent Brain-Computer Interface Based on Visual Stimulation through Closed Eyelids.

Authors:  Han-Jeong Hwang; Valeria Y Ferreria; Daniel Ulrich; Tayfun Kilic; Xenofon Chatziliadis; Benjamin Blankertz; Matthias Treder
Journal:  Sci Rep       Date:  2015-10-29       Impact factor: 4.379

4.  Amyotrophic Lateral Sclerosis and Myasthenia Gravis Overlap Syndrome: A Review of Two Cases and the Associated Literature.

Authors:  Hongfei Tai; Liying Cui; Yuzhou Guan; Mingsheng Liu; Xiaoguang Li; Yan Huang; Jing Yuan; Dongchao Shen; Dawei Li; Feifei Zhai
Journal:  Front Neurol       Date:  2017-05-22       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.